Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 13Rectal Neoplasms 10Esophageal Neoplasms 7Colorectal Neoplasms 7Stomach Neoplasms 6Esophageal Squamous Cell Carcinoma 6Uterine Cervical Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma Of Esophagus 5Squamous Cell Carcinoma of Head and Neck 4Neuroblastoma 4Neoplasm Metastasis 4Nasopharyngeal Carcinoma 4Colonic Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Lung Neoplasms 3Liposarcoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Prostatic Neoplasms 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Multiple Myeloma 2Melanoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2

Interventions

Melphalan 3tebentafusp 1sargramostim 1fotemustine 1aflibercept 1Ranibizumab 1Nivolumab 1Neoadjuvant Therapy 1Melatonin 1MART-1 Antigen 1Ipilimumab 1Eye Enucleation 1Dacarbazine 1Colony-Stimulating Factors 1Chemotherapy, Cancer, Regional Perfusion 1Brachytherapy 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Uveal Melanoma × Neoadjuvant Therapy × Clear all
NCT00324727 2021-06-21

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Delcath Systems Inc.

Phase 3 Completed
93 enrolled
Dermatologic

Uveal Melanoma, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡